Press Releases November 7, 2022: MaaT Pharma Announces Participation in Scientific and Investor Conferences in November MaaT Pharma Announces Participation in Scientific and Investor Conferences in November Lyon, France, November 7th, 2022,…MaaT PharmaNovember 7, 2022
Press Releases November 3, 2022: MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH) Annual Meeting MaaT Pharma Announces Oral and Poster Presentations at the 64th American Society of Hematology (ASH)…MaaT PharmaNovember 3, 2022
Press Releases October 7, 2022: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…MaaT PharmaOctober 7, 2022
Press Releases October 4, 2022: MaaT Pharma Appoints Nathalie Corvaïa as Chief Scientific Officer and Strengthens its R&D activities in Immuno-Oncology MaaT Pharma Appoints Nathalie Corvaïa as Chief Scientific Officer and Strengthens its R&D activities in…MaaT PharmaOctober 4, 2022
Press Releases September 29, 2022: MaaT Pharma Publishes its Half Year Results and Provides a Business Overview MaaT Pharma Publishes its Half Year Results and Provides a Business Overview For the first…MaaT PharmaSeptember 29, 2022
Press Releases September 8, 2022: MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September MaaT Pharma Announces Participation in Three Upcoming Investor Conferences in September Lyon, France, September 8th,…MaaT PharmaSeptember 8, 2022
Press Releases September 6, 2022: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…MaaT PharmaSeptember 6, 2022
Press Releases August 10, 2022: MaaT Pharma Announces Update on U.S. FDA Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease MaaT Pharma Announces Update on U.S. FDA Investigational New Drug Application for MaaT013 in Patients…MaaT PharmaAugust 10, 2022
Press Releases August 01, 2022: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital…MaaT PharmaAugust 1, 2022
Press Releases July 28, 2022: MaaT Pharma Reports Cash and Revenues for Q2 2022 MaaT Pharma Reports Cash and Revenues for Second Quarter 2022 As of June 30, 2022,…MaaT PharmaJuly 28, 2022